The move will enable the company to strengthen its foothold in the US and establish its presence in the fast-growing global biologics CDMO space.

So far, China has made no official public threat about weaponizing its dominant position in this segment of the pharmaceutical industry. But Trump’s tariffs on the sector, if imposed, could worsen ...

Some of the biggest U.S. investment announcements from Europe so far have come from the pharmaceutical sector, with Swiss ...

The updatedannual Fortune 500 list ranking the largest public companies by revenue was released Monday. Fortune said the 500 ...

* India has emerged as the medial tourism hub of the world providing cost-effective treatments with the latest technology enabled by several pathbreaking reforms and provisions. * Access to affordable ...

Wrapping up Q1 earnings, we look at the numbers and key takeaways for the branded pharmaceuticals stocks, including Pfizer ...

Pharmaceutical manufacturer Sigachi Industries has announced a 10 per cent final dividend for FY25 after posting a strong Q4 ...

Asad Haider, head of the healthcare business unit within Goldman Sachs Research, now forecasts the market for anti-obesity drugs, particularly those using injectable versions of GLP 1-based drugs, to ...

Every spring horseshoe crabs come to South Carolina beaches to reproduce. A volunteer initiative with the SCDNR helps ...

Two of Ace investor and one of India’s Warren Buffett, Madhusudan Kela’s favourite stocks now trade at discounts of over 50%.

A federal program allows nonprofit hospitals and clinics to buy prescription drugs at steep discounts, charge insurers full ...

Seven pharmaceutical giants with a presence in New Jersey have announced billions in expansions. The timing is no surprise, health care analysts say.